logo

Juniper Pharmaceuticals Inc (JNP)



Trade JNP now with
  Date
  Headline
5/10/2018 7:06:11 AM Juniper Pharma Posts Q1 Net Income Of $0.8 Mln Or $0.06/share
4/25/2018 8:10:35 AM Juniper Pharmaceuticals Licenses Intravaginal Ring Platform To Daré Bioscience
3/21/2018 8:32:34 AM Juniper Pharmaceuticals Appoints Richard Messina To Board
3/8/2018 8:10:30 AM Juniper Pharma FY Total Revenues Decrease 8.4% To $50.0 Mln
1/31/2018 9:27:08 AM Juniper Pharma To Explore Strategic Alternatives
1/8/2018 7:12:15 AM Juniper Pharma Announces 4.5-Year Extension Through 2024 Of CRINONE Supply Agreement With Merck KGaA
9/11/2017 4:06:15 PM Juniper Pharmaceuticals Appoints Jennifer Good To Board Of Directors
5/4/2017 7:46:23 AM Juniper Pharma Q1 Basic Loss Per Share $0.13 Vs Loss $0.15 Last Year
4/12/2017 7:06:31 AM Krensavage Asset Management, 2.2% Shareholder, Urges Juniper Pharmaceuticals To Consider Sale Of Company
3/7/2017 6:03:56 AM Juniper Pharma Q4 Net Income $9.6 Mln Or $0.88/Shr Vs Loss Of $1.0 Mln Or $0.09/Shr Last Year
12/20/2016 8:03:22 AM Juniper Pharma Says Names Jeffrey Young CFO, Effective Jan. 1
11/15/2016 6:03:13 AM Juniper Pharma Monetizes U.S. Crinone Royalty Stream With Allergan
11/15/2016 6:00:47 AM Juniper Pharma Q3 Total Revenues Up 5% To $11.6 Mln From $11.0 Mln Last Year
8/17/2016 5:31:11 PM Juniper Pharmaceuticals Trading Expected To Resume At 5:55 PM ET